Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST)

NCT03895658 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.

NCT NCT03895658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03895658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST)
Lead sponsor
National Institute of Mental Health (NIMH)
Phase
Phase 1
Overall status
Withdrawn
Start date
February 26, 2025
Completion date
February 26, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

unipolar depression